How to Help Your Patients Find Sudo-Tab In Stock: A Provider's Guide

Patients frequently encounter barriers when trying to purchase pseudoephedrine (Sudo-Tab) at the pharmacy. As their healthcare provider, you can play a key role in reducing this frustration — both through how you write prescriptions and through what you communicate at the point of care.

This guide covers practical steps providers can take to help patients access Sudo-Tab successfully in 2026.

Why Patients Struggle to Find Sudo-Tab

Sudo-Tab (pseudoephedrine) is not in a drug shortage as of 2026. It is widely available at pharmacies. The primary barriers are regulatory, not supply-related:

The Combat Methamphetamine Epidemic Act (CMEA) requires all pseudoephedrine to be kept behind the pharmacy counter

Patients must show photo ID and sign a purchase logbook

Daily and monthly purchase limits apply (3.6 g/day, 9 g/month)

Some states (historically Oregon and Mississippi) require a prescription

Seasonal demand spikes can cause temporary local stock-outs

Strategy 1: Write a Prescription (Even for an OTC Drug)

Pseudoephedrine is technically an OTC drug in most states — but nothing prevents you from writing a prescription for it. Doing so has several advantages for patients:

Streamlines the pharmacy transaction — the pharmacist already has authorization in hand

May qualify for insurance coverage if the patient has an FSA or HSA account, or if their plan covers certain OTC drugs when prescribed

Required in states like Oregon and Mississippi, which mandate prescriptions for pseudoephedrine

May help patients enrolled in medication assistance programs qualify for the medication

Note: There is ongoing discussion among pharmacy groups and the DEA about whether federal daily purchase limits apply when pseudoephedrine is dispensed pursuant to a prescription. Some pharmacy associations have argued that prescriptions should be exempt. Until definitive guidance is issued, some pharmacies may still apply limits. Check with the dispensing pharmacy.

Strategy 2: Specify the Formulation Clearly on the Prescription

Pseudoephedrine comes in multiple strengths and forms. Being specific reduces pharmacy confusion and substitution errors:

Pseudoephedrine HCl 30 mg tablet — every 4–6 hours PRN nasal congestion

Pseudoephedrine HCl 60 mg tablet — every 4–6 hours PRN

Pseudoephedrine HCl ER 120 mg tablet — every 12 hours PRN

Pseudoephedrine HCl ER 240 mg tablet — once daily PRN

Strategy 3: Counsel Patients Before They Leave the Office

A few simple points at the point of care can prevent wasted trips and patient frustration:

Tell patients: "You'll need to ask at the pharmacy counter — it won't be on the shelf."

Remind them to bring a photo ID to the pharmacy

Advise them to call ahead if they're unsure of stock — or use a pharmacy finder tool

Tell patients to avoid taking extended-release tablets close to bedtime (can cause insomnia)

Review interactions — especially MAOI, other sympathomimetics, and caffeine

Strategy 4: Recommend medfinder to Save Your Patients Time

One of the most practical things you can tell patients is to use medfinder. medfinder calls pharmacies in your patient's area to check which ones have Sudo-Tab (or any other medication) in stock, and texts the results directly to the patient. This saves patients from calling 5–10 pharmacies themselves, which is especially valuable during peak cold season when some locations may be temporarily out.

Strategy 5: Consider Long-Term Alternatives for Chronic Patients

For patients who require ongoing nasal congestion management, repeated reliance on pseudoephedrine is not ideal. Consider transitioning chronic patients to:

Intranasal corticosteroids (fluticasone, mometasone, budesonide) — first-line for chronic allergic rhinitis

Allergy evaluation and immunotherapy for underlying sensitization

ENT referral if structural issues (nasal polyps, deviated septum) are suspected

Documentation and Liability Notes

When recommending pseudoephedrine, document your clinical rationale in the chart, particularly if the patient has risk factors such as hypertension or cardiovascular disease. If prescribing rather than recommending OTC purchase, document that the clinical benefit was judged to outweigh the cardiovascular risks. For patients on antihypertensives, note that pseudoephedrine may reduce the effectiveness of their blood pressure medications and monitor accordingly.

For more on the clinical and regulatory landscape, see: Sudo-Tab Shortage: What Providers and Prescribers Need to Know in 2026